Canada · Health Canada Drug Product Database

LYTEPREP

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 63047
DIN: 02239569
Form: Powder
Company as listed by source: THERAPEX DIVISION DE E-Z-EM CANADA INC
Source status: Cancelled Post Market (2005-09-26)
Source last updated: 2025-03-22

Source-listed ingredients

POLYETHYLENE GLYCOL 3350 — 236 G — per 1 BOTTLE
SODIUM SULFATE — 22.74 G — per 1 BOTTLE
SODIUM BICARBONATE — 6.74 G — per 1 BOTTLE
SODIUM CHLORIDE — 5.86 G — per 1 BOTTLE
POTASSIUM CHLORIDE — 2.97 G — per 1 BOTTLE

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open Health Canada Drug Product Database →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse Canada records →